COVID-19 key visual

Siemens Healthineers Spring Forum on COVID-19 Testing

Join our hybrid event!

Online at siemens-healthineers.com/eccmid

In-person at ECCMID 2022, Lisbon, Portugal

Changing COVID-19 testing demands require clinical laboratories to keep up with an increasing number of patients, samples, and emerging variants. Siemens Healthineers provides the flexibility you want for the clinical results you need with innovative, COVID-19 testing solutions.

While at the Spring Forum on COVID-19 Testing, attend a scientific symposium, meet our experts, and explore our COVID-19 testing portfolio, from a highly sensitive RT-PCR test that can detect Omicron sublineage BA.21 to high throughput or point of care antigen and antibody assays.

Hybrid Event Details

An orange tram goes down the track in the old city in Lisbon, Portugal

Join Siemens Healthineers at ECCMID 2022 in Lisbon, Portugal

Dates: Saturday, 23 April 2022 – Tuesday, 26 April 2022

Location: Online & Portugal Altice Arena, Lisbon, Portugal, Booth #2-7.2

Hybrid event: Online and in-person

Visit our ECCMID Booth

How can your laboratory deliver more impactful results for the detection and management of COVID-19?

Explore a full portfolio of COVID-19 testing solutions from Siemens Healthineers that consistently delivers sensitivity and performance—to get us to what’s next on the path to normalcy.


Attend our ECCMID Symposium

orange icon for symposium

This one-hour integrated symposium will focus on testing for respiratory viruses including SARS-CoV-2 and other seasonal respiratory viruses using molecular methods. The challenging and dynamic nature of this field will be highlighted along with a discussion on how labs are addressing the evolution of testing needs including SARS-CoV-2 variants, seasonal viruses, and potential future outbreaks.

Testing for respiratory viruses: a dynamic field in an evolving environment

Two years of SARS-CoV-2 PCR testing in a large university hospital in Rome: Lessons and findings

Dr. Simona Marchetti, PhD 
Department of Laboratory and Infectious Science, "Fondazione Policlinico Universitario A. Gemelli IRCCS" 
Rome, Italy

Can diagnostic stewardship and integration of winter surge planning for respiratory virus diagnostics be the basis for coping with the next pandemic? 

Pr. Peter Coyle, MD, Senior Consultant
Head of Virology, Hamad General Hospital
Doha, Qatar 


Visit our Virtual Platform

Virtual Platform Icon

Experience our interactive platform with recorded presentations and whitepapers highlighting our innovative COVID-19 testing solutions, including reflex testing for emerging variants. 

From the lab to the point of care, Siemens Healthineers offers a full portfolio of COVID-19 testing solutions that consistently delivers sensitivity and performance—to get us to what’s next.

The molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit

Molecular Testing

Gold standard for accurate and early detection of COVID-19 infection in patients.

Automated Real-time PCR RNA Testing 

Innovative reflex testing approach for SARS-CoV-2 variant identification.

Atellica CoV2 antigen lab test

Large-scale Testing and Diagnosis

Clinicians use diagnostic tests to determine if people have current COVID-19 infections, enabling patient management decisions.

High-throughput Lab Antigen Testing

Intended for fast, safe and accurate, high-scale community screening.

CLINITEST® Rapid COVID-19 Self-Test

Satellite Testing

Near-patient testing can be used to identify and isolate infected people more quickly.

Point-of-care Rapid Antigen Testing

Rapid antigen testing can help communities get ahead of the spread.

Total Antibody Test

Management and Monitoring

Management and monitoring are critical in determining the full scope of the disease, combating the pandemic, and rebuilding public confidence.

High-throughput Lab Antibody Testing

Highly accurate for detection and monitoring of immune response through infection and in vaccination.

Point-of-care Antibody Testing


2
3
4